Cardio Diagnostics Valuation
| CDIO Stock | USD 0.43 0.02 4.44% |
Cardio Diagnostics is undervalued. Cardio Diagnostics shows a prevailing Real Value of $0.82 per share. The current price of the firm is $0.43. Our model approximates the value of Cardio Diagnostics from analyzing the firm fundamentals such as Operating Margin of (214.13) %, return on equity of -2.76, and Shares Outstanding of 52.15 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cardio Diagnostics' valuation include:
Price Book 2.3575 | Enterprise Value | Enterprise Value Ebitda (22.48) | Price Sales 632.8226 | Enterprise Value Revenue 440.4599 |
Undervalued
Today
Please note that Cardio Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of Cardio Diagnostics is based on 3 months time horizon. Increasing Cardio Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cardio Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cardio Stock. However, Cardio Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.43 | Real 0.82 | Target 2.0 | Hype 0.42 | Naive 0.56 |
The intrinsic value of Cardio Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cardio Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cardio Diagnostics Holdings helps investors to forecast how Cardio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cardio Diagnostics more accurately as focusing exclusively on Cardio Diagnostics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cardio Diagnostics' intrinsic value based on its ongoing forecasts of Cardio Diagnostics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cardio Diagnostics' closest peers.
Cardio Diagnostics Cash |
|
Cardio Valuation Trend
Knowing Cardio Diagnostics' actual value is paramount for traders when making sound investment determinations. Using both Cardio Diagnostics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Cardio Diagnostics Total Value Analysis
Cardio Diagnostics Holdings is currently forecasted to have valuation of 15.37 M with market capitalization of 22.58 M, debt of 663.1 K, and cash on hands of 9.66 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cardio Diagnostics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.37 M | 22.58 M | 663.1 K | 9.66 M |
Cardio Diagnostics Investor Information
The book value of the company was currently reported as 0.12. The company recorded a loss per share of 0.31. Cardio Diagnostics had not issued any dividends in recent years. Based on the key indicators related to Cardio Diagnostics' liquidity, profitability, solvency, and operating efficiency, Cardio Diagnostics Holdings is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Cardio Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cardio Diagnostics has an asset utilization ratio of 0.0191 percent. This suggests that the Company is making $1.91E-4 for each dollar of assets. An increasing asset utilization means that Cardio Diagnostics Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Cardio Diagnostics Ownership Allocation
Cardio Diagnostics holds a total of 52.15 Million outstanding shares. Cardio Diagnostics Holdings shows 7.68 percent of its outstanding shares held by insiders and 4.9 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cardio Diagnostics Profitability Analysis
The company reported the previous year's revenue of 2.02 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 35.69 K.About Cardio Diagnostics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cardio Diagnostics Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cardio Diagnostics based exclusively on its fundamental and basic technical indicators. By analyzing Cardio Diagnostics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cardio Diagnostics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardio Diagnostics. We calculate exposure to Cardio Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cardio Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2 K | 1.4 K | |
| Pretax Profit Margin | (441.79) | (463.88) | |
| Operating Profit Margin | -4.1 K | -4.3 K | |
| Net Loss | (441.79) | (463.88) | |
| Gross Profit Margin | (14.26) | (14.97) |
Cardio Diagnostics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 24.4 M |
Cardio Diagnostics Current Valuation Indicators
Cardio Diagnostics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cardio Diagnostics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cardio Diagnostics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cardio Diagnostics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cardio Diagnostics' worth.When determining whether Cardio Diagnostics is a strong investment it is important to analyze Cardio Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardio Diagnostics' future performance. For an informed investment choice regarding Cardio Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.31) | Revenue Per Share | Quarterly Revenue Growth (0.34) | Return On Assets | Return On Equity |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.